Back

MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation

4 April 2022 (18:30 - 18:40)
Organised by:
Congress Presentation Part of: Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2022

7 More presentations in this session

Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation
Slides Video
Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation - discussion.
Video
Presentation thumbnail
MANIFEST-PF - discussion.
Video
Presentation thumbnail
High radiofrequency power for faster and safer pulmonary vein ablation trial (POWER FAST III)
Slides Video
Presentation thumbnail
POWER FAST III - discussion.
Video

Access the full session

Session thumbnail
Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences
Video

The Event

Event poster

EHRA 2022

4 April 2022 18:30 CET
You may be interested in
thumbnail
Congress Presentation
MANIFEST-PF .
26 August 2022
thumbnail
Congress Presentation
BEAT-AF: an insider's view
11 April 2026
thumbnail
Congress Presentation
1-yr outcomes from the MANIFEST-PF registry
16 April 2023
thumbnail
Congress Presentation
Risk of mechanical or electrical complications with pulsed field ablation in patients with cardiac implantable electronic devices
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources